InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) CEO Richard Dilorio sold 5,398 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $8.87, for a total transaction of $47,880.26. Following the completion of the sale, the chief executive officer now owns 416,659 shares in the company, valued at $3,695,765.33. The trade was a 1.28 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Richard Dilorio also recently made the following trade(s):
- On Monday, November 25th, Richard Dilorio sold 20,000 shares of InfuSystem stock. The shares were sold at an average price of $9.32, for a total transaction of $186,400.00.
InfuSystem Stock Performance
INFU opened at $8.85 on Thursday. The firm has a fifty day moving average price of $7.29. The stock has a market capitalization of $188.19 million, a PE ratio of 147.50 and a beta of 1.45. InfuSystem Holdings, Inc. has a fifty-two week low of $5.74 and a fifty-two week high of $10.99. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50.
Analyst Ratings Changes
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing | Ad
Starting with what I call Exec. Order 001.
It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
I put all the details together for you here — but please hurry.
INFU has been the subject of several analyst reports. StockNews.com raised InfuSystem from a "buy" rating to a "strong-buy" rating in a report on Friday, November 8th. B. Riley initiated coverage on InfuSystem in a report on Thursday, September 26th. They issued a "buy" rating and a $13.00 price target for the company.
Get Our Latest Report on InfuSystem
Hedge Funds Weigh In On InfuSystem
Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in InfuSystem by 1.7% during the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company's stock worth $9,288,000 after purchasing an additional 18,432 shares in the last quarter. First Eagle Investment Management LLC raised its stake in shares of InfuSystem by 10.0% during the 2nd quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company's stock worth $4,549,000 after buying an additional 60,813 shares during the period. Geode Capital Management LLC lifted its position in shares of InfuSystem by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 436,508 shares of the company's stock valued at $2,925,000 after buying an additional 7,550 shares in the last quarter. State Street Corp grew its stake in InfuSystem by 1.1% in the 3rd quarter. State Street Corp now owns 267,012 shares of the company's stock valued at $1,789,000 after acquiring an additional 3,019 shares during the period. Finally, Greenwood Capital Associates LLC increased its holdings in InfuSystem by 14.0% in the 3rd quarter. Greenwood Capital Associates LLC now owns 119,062 shares of the company's stock worth $798,000 after acquiring an additional 14,587 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock.
InfuSystem Company Profile
(
Get Free Report)
InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
